Of the GRHL1-3 factors, GRHL2 acts as an oncogene in hepatocellular carcinoma (HCC) and HCC cells show decreased proliferation following GRHL2 downregulation. This evidence concerns the gene GRHL1 and hepatocellular carcinoma.